KYMERA THERAPEUTICS, INC. (KYMR)

SEC filing

KYMERA THERAPEUTICS, INC.

KYMR · CIK 1815442

4 · Oct 1, 2026 · Director, Chief Executive Officer Mainolfi Nello sold 30K shares at $113.80/share ($3.4M); exercised options for 60K shares

Director, Chief Executive Officer Mainolfi Nello sold 30K shares at $113.80/share ($3.4M); exercised options for 60K shares

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).